Celgene Corp (NASDAQ:CELG)

79.44
Delayed Data
As of Jun 19
 +1.71 / +2.20%
Today’s Change
74.13
Today|||52-Week Range
147.17
-23.88%
Year-to-Date

Today’s Trading

Previous close77.73
Today’s open77.42
Day’s range77.14 - 79.58
Volume8,047,600
Average volume (3 months)7,251,006
Market cap$61.8B
Data as of 4:00pm ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)+46.18%
Earnings growth (this year)+14.82%
Earnings growth (next 5 years)+17.70%
Revenue growth (last year)+17.40%
P/E ratio22.1
Price/Sales6.58
Price/Book9.36

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.23-0.56%
BMYBristol-Myers Squibb-0.01-0.02%
NVONovo Nordisk-0.08-0.18%
ABBVAbbVie-0.47-0.48%
Data as of 4:02pm ET, 06/19/2018

Financials

Next reporting dateJuly 26, 2018
EPS forecast (this quarter)$2.11
Annual revenue (last year)$12.8B
Annual profit (last year)$2.9B
Net profit margin22.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
Executive VP, Chief Financial &
Accounting Officer
Peter N. Kellogg
Corporate headquarters
Summit, New Jersey

Forecasts